rs45517202
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 4P and 1B. PM2PM5BP4
The NM_000548.5(TSC2):c.1796A>G(p.Lys599Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,460,946 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. K599M) has been classified as Pathogenic.
Frequency
Consequence
NM_000548.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000399 AC: 1AN: 250664Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135824
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1460946Hom.: 0 Cov.: 34 AF XY: 0.00000138 AC XY: 1AN XY: 726784
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Tuberous sclerosis 2 Uncertain:1Benign:1
- -
- -
not provided Uncertain:1
p.Lys599Arg (AAG>AGG):c.1796 A>G in exon 17 of the TSC2 gene (NM_000548.3)The Lys599Arg missense change has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. A different amino acid substitution at the same position, Lys599Met, was previously reported as a de novo mutation in a patient with sporadic tuberous sclerosis, and some in vitro studies suggested it may alter protein function; however, subsequent studies revealed no effect on protein function, and at this time the clinical significance of Lys599Met is unknown (Niida et al., 1999; Tee et al., 2002; Nellist et al., 2005; Hoogeveen-Westerveld et al., 2011; LOVD; an external gene datebase). The NHLBI ESP Exome Variant Project has not identified Lys599Arg in approximately 6,500 individuals of European or African American ethnicity, indicating that it is not a common benign variant in these populations. The amino acid substitution is conservative, as both Lysine and Arginine are positively charged amino acids. Lys599Arg alters a position in the tuberin protein that is not conserved. While one in silico algorithm predicts it may be damaging to protein structure/function, another model predicts it is likely benign. Therefore, based on the currently available information, it is unclear whether Lys599Arg is a disease-causing mutation or a rare benign variant. The variant is found in INFANT-EPI panel(s). -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.K599R variant (also known as c.1796A>G), located in coding exon 16 of the TSC2 gene, results from an A to G substitution at nucleotide position 1796. The lysine at codon 599 is replaced by arginine, an amino acid with highly similar properties. This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at